Eli Lilly and Company (LLY) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 50,000명 · CEO David A. Ricks
- 주가
- $1,417.54 +3.19%
- 시가총액
- $1.33조
- 기업가치
- $1.38조
- 최근 실적
- Q3 '26 2026-10-29 제출
- 다음 실적
- 2027-02-03 EPS 추정 $11.07
Eli Lilly and Company (LLY)의 Q3 '26말 현금 및 단기투자는 $48.9억, 리스 포함 차입금은 $495억입니다. 자산총계 $1480억, 부채총계 $1080억, 주주지분 $403억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $28.2억 | $24.6억 | $32.2억 | $33.7억 | $32.7억 | $30.9억 | $33.8억 | $97.9억 | $71.6억 | $51.4억 | $88.9억 | $48.9억 | |
| 단기투자 | $1.09억 | $1.26억 | $1.4억 | $1.49억 | $1.55억 | $1.27억 | $1.7억 | $1.22억 | $1.05억 | $1.46억 | $6000만 | $0 | |
| 매출채권 | $113억 | $100억 | $131억 | $121억 | $133억 | $140억 | $172억 | $195억 | $202억 | $212억 | $235억 | $252억 | |
| 재고자산 | $57.7억 | $61억 | $64.8억 | $74.6억 | $75.9억 | $93.1억 | $110억 | $122억 | $137억 | $145억 | $168억 | $182억 | |
| 기타 유동자산 | $1.5억 | $1.39억 | $1.42억 | $1.35억 | $1.11억 | $7240만 | $6880만 | $2.72억 | $1.47억 | $2.14억 | $8600만 | $9100만 | |
| 유동자산 | $257억 | $252억 | $302억 | $314억 | $327억 | $413억 | $499억 | $621억 | $556억 | $548억 | $647억 | $653억 | |
| 유형자산(순액) | $129억 | $136억 | $148억 | $162억 | $171억 | $185억 | $205억 | $223억 | $247억 | $265억 | $293억 | $322억 | |
| 장기투자 | $30.5억 | $30.9억 | $29.2억 | $32억 | $32.2억 | $32.2억 | $32.1억 | $28.1억 | $28억 | $31.2억 | $38.6억 | $40.1억 | |
| 영업권 | $49.4억 | $49.4억 | $57.7억 | $57.7억 | $57.7억 | $57.7억 | $57.7억 | $59억 | $59억 | $61.3억 | $88.5억 | $98.7억 | |
| 무형자산 | $69.1억 | $67.6억 | $66.4억 | $65.4억 | $61.7억 | $60.1억 | $59.1억 | $64.5억 | $65.2억 | $73.7억 | $181억 | $181억 | |
| 이연법인세자산 | $54.8억 | $56.3억 | $66.6억 | $73.9억 | $80억 | $85.7억 | $94.3억 | $89.6억 | $99.6억 | $114억 | $100억 | $110억 | |
| 기타 비유동자산 | $49.9억 | $47.1억 | $48.6억 | $51.2억 | $57.2억 | $60.7억 | $62.3억 | $64.3억 | $69.9억 | $72.3억 | $74.8억 | $77억 | |
| 비유동자산 | $383억 | $388억 | $417억 | $442억 | $460억 | $481억 | $511억 | $529억 | $568억 | $617억 | $776억 | $828억 | |
| 자산총계 | $640억 | $639억 | $719억 | $756억 | $787억 | $894억 | $1010억 | $1150억 | $1120억 | $1170억 | $1420억 | $1480억 | |
| 부채 | |||||||||||||
| 매입채무 | $26억 | $24.7억 | $29.2억 | $28.9억 | $32.3억 | $34.4억 | $40.8억 | $42.6억 | $53.8억 | $50.3억 | $61.1억 | $57.9억 | |
| 미지급비용 | $117억 | $8.44억 | $124억 | $17억 | $115억 | $116억 | $145억 | $176억 | $174억 | $175억 | $229억 | $265억 | |
| 단기차입금 | $69억 | $16.5억 | $51.6억 | $20.7억 | $51.2억 | $40.2억 | $57.2억 | $16.3억 | $16.4억 | $40억 | $70.5억 | $25.2억 | |
| 미지급세금 | $38.5억 | $41.9억 | $35억 | $38.8억 | $0 | $61.8억 | $69.6억 | $94.4억 | $0 | $52.9억 | $54.6억 | $0 | |
| 기타 유동부채 | $49.3억 | $136억 | $54.2억 | $180억 | $71.5억 | $48.8억 | $63.8억 | $71.8억 | $108억 | $101억 | $117억 | $122억 | |
| 유동부채 | $273억 | $186억 | $271억 | $247억 | $284억 | $301억 | $390억 | $401억 | $352억 | $366억 | $477억 | $470억 | |
| 장기차입금 | $183억 | $246억 | $237억 | $290억 | $285억 | $345억 | $342억 | $409억 | $409억 | $394억 | $479억 | $470억 | |
| 이연법인세부채 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $54.6억 | $0 | |
| 기타 비유동부채 | $75.3억 | $78.9억 | $73.9억 | $75.7억 | $75.4억 | $89.7억 | $93.7억 | $101억 | $98.5억 | $93.7억 | $73.4억 | $138억 | |
| 비유동부채 | $258억 | $324억 | $311억 | $366억 | $361억 | $435억 | $436억 | $509억 | $507억 | $487억 | $607억 | $608억 | |
| 부채총계 | $531억 | $510억 | $582억 | $613억 | $644억 | $735억 | $826억 | $911억 | $859억 | $854억 | $1080억 | $1080억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $5.94억 | $5.94억 | $5.94억 | $5.94억 | $5.92억 | $5.93억 | $5.92억 | $5.91억 | $5.9억 | $5.9억 | $5.88억 | $5.88억 | |
| 이익잉여금 | $103억 | $126억 | $132억 | $136억 | $135억 | $151억 | $174억 | $223억 | $245억 | $295억 | $319억 | $380억 | |
| 기타포괄손익누계액 | -$43.3억 | -$43억 | -$43.8억 | -$42.7억 | -$43.2억 | -$37.7억 | -$37.2억 | -$32.1억 | -$28.8억 | -$28.3억 | -$27.6억 | -$26.3억 | |
| 주주지분 | $108억 | $128억 | $136억 | $142억 | $142억 | $158억 | $183억 | $238억 | $265억 | $312억 | $339억 | $403억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $252억 | $262억 | $289억 | $311억 | $336억 | $385억 | $399억 | $425억 | $425억 | $434억 | $549억 | $495억 | |
| 순차입금(차입금 - 현금) | $224억 | $238억 | $257억 | $278억 | $304억 | $354억 | $365억 | $327억 | $353억 | $382억 | $460억 | $446억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $45.8억 | $65.4억 | $73.2억 | $23.4억 | $36.6억 | $38.2억 | $20.7억 | $28.2억 | $32.7억 | $71.6억 | |
| 단기투자 | $14.6억 | $15억 | $8820만 | $1.01억 | $2420만 | $9010만 | $1.45억 | $1.09억 | $1.55억 | $1.05억 | |
| 매출채권 | $47.7억 | $52.6억 | $57.8억 | $55.4억 | $69.3억 | $81.3억 | $85.6억 | $113억 | $133억 | $202억 | |
| 재고자산 | $35.6억 | $44.6억 | $31억 | $31.9억 | $39.8억 | $38.9억 | $43.1억 | $57.7억 | $75.9억 | $137억 | |
| 기타 유동자산 | $0 | $0 | $22.3억 | $0 | $0 | $0 | $730만 | $1.5억 | $1.11억 | $1.47억 | |
| 유동자산 | $151억 | $192억 | $205억 | $137억 | $175억 | $185억 | $180억 | $257억 | $327억 | $556억 | |
| 유형자산(순액) | $82.5억 | $88.3억 | $80억 | $84.1억 | $86.8억 | $89.9억 | $101억 | $129억 | $171억 | $247억 | |
| 장기투자 | $52.1억 | $56.8억 | $20.2억 | $19.6억 | $29.7억 | $32.1억 | $29억 | $30.5억 | $32.2억 | $28억 | |
| 영업권 | $39.7억 | $43.7억 | $13.7억 | $36.8억 | $37.7억 | $38.9억 | $40.7억 | $49.4억 | $57.7억 | $59억 | |
| 무형자산 | $43.6억 | $40.3억 | $10.7억 | $66.2억 | $74.5억 | $76.9억 | $72.1억 | $69.1억 | $61.7억 | $65.2억 | |
| 이연법인세자산 | $0 | $0 | $26.1억 | $25.7억 | $28.3억 | $24.9억 | $27.9억 | $54.8억 | $80억 | $99.6억 | |
| 기타 비유동자산 | $19.1억 | $28.7억 | $83억 | $23.4억 | $34.8억 | $40.8억 | $43.4억 | $49.9억 | $57.2억 | $69.9억 | |
| 비유동자산 | $237억 | $258억 | $234억 | $256억 | $292억 | $304억 | $315억 | $383억 | $460억 | $568억 | |
| 자산총계 | $388억 | $450억 | $439억 | $393억 | $466억 | $488억 | $495억 | $640억 | $787억 | $1120억 | |
| 부채 | |||||||||||
| 매입채무 | $13.5억 | $14.1억 | $12.1억 | $14.1억 | $16.1억 | $16.7억 | $19.3억 | $26억 | $32.3억 | $53.8억 | |
| 미지급비용 | $9.72억 | $10.7억 | $48.5억 | $49.3억 | $10.7억 | $10.3억 | $87.8억 | $117억 | $115억 | $0 | |
| 단기차입금 | $19.4억 | $37.1억 | $11억 | $15억 | $870만 | $15.4억 | $15억 | $69억 | $51.2억 | $16.4억 | |
| 미지급세금 | $1.19억 | $5.33억 | $3.93억 | $1.61억 | $4.95억 | $1.27억 | $4.75억 | $38.5억 | $0 | $58.8억 | |
| 기타 유동부채 | $66.1억 | $78.2억 | $36.9억 | $31억 | $93억 | $107억 | $39.1억 | $49.3억 | $71.5억 | $282억 | |
| 유동부채 | $110억 | $145억 | $119억 | $118억 | $125억 | $151억 | $171억 | $273억 | $284억 | $352억 | |
| 장기차입금 | $83.7억 | $99.3억 | $92억 | $138억 | $166억 | $153억 | $147억 | $183억 | $285억 | $409억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $4.87억 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $0 | $0 | $13.1억 | $21.9억 | $21억 | $17.3억 | $8730만 | $0 | $0 | $0 | |
| 기타 비유동부채 | $53.7억 | $88.5억 | $106억 | $83.2억 | $96.4억 | $75.2억 | $67.5억 | $75.3억 | $75.4억 | $98.5억 | |
| 비유동부채 | $137억 | $188억 | $211억 | $248억 | $283억 | $246억 | $216억 | $258억 | $361억 | $507억 | |
| 부채총계 | $247억 | $333억 | $330억 | $366억 | $408억 | $397억 | $387억 | $531억 | $644억 | $859억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $6.89억 | $6.88억 | $6.61억 | $5.99억 | $5.98억 | $5.96억 | $5.94억 | $5.94억 | $5.92억 | $5.9억 | |
| 이익잉여금 | $160억 | $139억 | $114억 | $49.2억 | $78.3억 | $89.6억 | $100억 | $103억 | $135억 | $245억 | |
| 기타포괄손익누계액 | -$82.9억 | -$87.3억 | -$87.4억 | -$65.2억 | -$95.1억 | -$43.4억 | -$38.4억 | -$43.3억 | -$43.2억 | -$28.8억 | |
| 주주지분 | $140억 | $116억 | $98.3억 | $26.1억 | $56.4억 | $89.8억 | $106억 | $108억 | $142억 | $265억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $103억 | $136억 | $103억 | $158억 | $166억 | $169억 | $162억 | $252억 | $336억 | $425억 | |
| 순차입금(차입금 - 현금) | $57.2억 | $71.1억 | $29.8억 | $135억 | $129억 | $131억 | $142억 | $224억 | $304억 | $353억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
데이터 기준일 2026-11-01